Literature DB >> 19667943

Liver transplantation trends and survival in the Asian population.

Nyingi M Kemmer1, Guy W Neff.   

Abstract

BACKGROUND: Studies to address the ethnic minorities in liver transplantation (LT) have focused traditionally on African Americans and Hispanics. Although, the Asian population accounts for 4.4% of the US population, there is limited information on transplantation trends for this ethnic group. The aim of this study was to evaluate the transplantation trends and determine survival patterns of Asian LT recipients.
METHODS: The United Network for Organ Sharing database was reviewed for all Asian adult (>18 years) recipients who underwent LT between 1998 and 2007 (n=1953). The data collected included demographics, diagnosis, survival data, and United Network for Organ Sharing regions.
RESULTS: During the study period 1953 Asians received liver transplantation. The most frequent indication for transplantation among Asians was HBV (28.1%) in contrast to the non-Asian group in which HCV (29.6%) was the most common. The 5-yr Patient and graft survival was 76%, 74%, 73%, 65% and 71%, 68%, 67% and 57% for Asian, Hispanic, White and Black respectively.
CONCLUSION: We found (1) regional variation and differences in liver disease pattern among Asian population; and (2) overall LT recipients of Asian ethnicity have a significant survival advantage in comparison to non-Asian groups.

Entities:  

Mesh:

Year:  2009        PMID: 19667943     DOI: 10.1097/TP.0b013e3181aed68c

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  Access to Liver Transplantation and Patient Survival among Asian Populations: Pre-Share 35 vs Post-Share 35.

Authors:  Y Zhang
Journal:  Int J Organ Transplant Med       Date:  2017-11-01

2.  Disparities in Social Determinants of Health Among Patients Receiving Liver Transplant: Analysis of the National Inpatient Sample From 2016 to 2019.

Authors:  Mahmoud M Mansour; Darian Fard; Sanket D Basida; Adham E Obeidat; Mohammad Darweesh; Ratib Mahfouz; Ali Ahmad
Journal:  Cureus       Date:  2022-07-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.